|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Oxygen Containing Hetero Ring > The Hetero Ring Is Five-membered > Chalcogen Bonded Directly To The Hetero Ring Chalcogen Bonded Directly To The Hetero RingChalcogen Bonded Directly To The Hetero Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/24/06 - 20060189684 - 3-phenylfuran-2-one derivatives as cox-2 inhibitor The present invention relates to 3-phenylfuran-2-ones of formula (I), processes for their preparation, pharmaceutical compositions containing them, and their medical uses. ... 05/18/06 - 20060106098 - Andrographolide and its derivatives as tnf-alpha antagonists Andrographolide and its derivatives represented by general formula (I) defined above are useful as TNFα (tumor necrosis factor alpha) antagonists or inhibitors which have inhibitory effect on the binding of TNFα to TNF-RI. Andrographolide exhibited inhibitor activity with IC50 values 60 μM on L929 cell proliferation/cytotoxicity assay without cell cytotoxicity. ... 03/23/06 - 20060063831 - Composition of labdane diterpenes extracted from andrographis paniculata, ufeful for the treatment of autoimmune diseases, and alzheimer disease by activation for ppr-gamma receptors inhibits the synthesis of pro-inflammatory cytokines, activates the PPAR-gamma receptor and diminishes nuclear factor kappa B. The compound is useful to treat auto-immune diseases, for organ and tissue transplantation, and to treat immunodeficiency (e.g., AIDS). ... 10/27/05 - 20050239877 - Synthetic lactone formulations and method of use Natural and synthetic compounds having a lactone structure methods for alleviation of pain, especially pain associated with disorders such as melanoma, leukemia, breast cancer, lung cancer, ovarian cancer, colon cancer, esophagus cancer, liver cancer, and lymphatic cancer. Initial studies have shown that patients can be taken off of morphine when ... 10/06/05 - 20050222251 - Dual inhibition of cyclooxygenase-2 and carbonic anhydrase Compounds of Formula I potently inhibit both cyclooxygenase-2 and carbonic anhydrases. Inhibition of carbonic anhydrases by a cyclooxygenase-2 inhibitor may affect significantly the safety and efficacy profiles of such a dual inhibitor in the treatment of cyclooxygenase-2 mediated disorders, compared to a cyclooxygenase-2 inhibitor without carbonic anhydrase inhibitory activity. ... 09/29/05 - 20050215628 - Andrographolide and analogues as inhibitors of tnfalpha and il-1beta expression wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound. ... 08/11/05 - 20050176814 - Deuterated substituted dihydrofuranones and medicaments containing these compounds The invention concerns deuterated substituted dihydrofuranones and pharmaceuticals containing these compounds. In addition, the invention concerns the use of deuterated substituted dihydrofuranones for the treatment of symptoms for the irritating states of degenerative joint disorders, of acute pain and primary dysmenorrhea. In addition, the invention discloses pharmaceutical compositions, which contain ... 06/30/05 - 20050143453 - Selective preventing and therapeutic agents for progressive lesion after organic damage An object of the present invention is to provide a pharmaceutical agents for preventing and/or treating the progressive lesion after the organic damage without inhibiting organic function or regeneration function thereof, by selectively suppressing the induction of cytotoxic effector macrophages which are induced into the damaged organs in response to ... ### FreshPatents.com Support |